FDA nears approval for anti-aging drugs for dogs
- San Francisco-based company Loyal has received conditional FDA approval for its anti-aging drug for dogs, LOY-001.
- The drug aims to address the shorter lifespans of large and giant-breed dogs by reducing the growth-promoting hormone IGF-1.
- If successful, LOY-001 could revolutionize pet care for larger canine companions, offering the promise of an extended and healthier life.
Insights by Ground AI
Does this summary seem wrong?
19 Articles
19 Articles
All
Left
7
Center
8
Right
3
It’s Pawwsible! The miracle drug that could extend your dog’s life
An anti-ageing drug for dogs has received a key nod from the US FDA. Developed by Loyal, a San Francisco-based biotech company, LOY-001 is an injection aimed at adding healthy years to the lifespan of larger canines
·Mumbai, India
Read Full ArticleCoverage Details
Total News Sources19
Leaning Left7Leaning Right3Center8Last UpdatedBias Distribution44% Center
Bias Distribution
- 44% of the sources are Center
44% Center
L 39%
C 44%
R 17%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage